Berry Genomics Co.,Ltd

Shenzhen Stock Exchange 000710.SZ

Berry Genomics Co.,Ltd Goodwill for the year ending December 31, 2023: USD 1.89 M

Berry Genomics Co.,Ltd Goodwill is USD 1.89 M for the year ending December 31, 2023, a -2.80% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.
  • Berry Genomics Co.,Ltd Goodwill for the year ending December 31, 2022 was USD 1.95 M, a -7.92% change year over year.
  • Berry Genomics Co.,Ltd Goodwill for the year ending December 31, 2021 was USD 2.11 M, a 2.73% change year over year.
  • Berry Genomics Co.,Ltd Goodwill for the year ending December 31, 2020 was USD 2.06 M, a 6.69% change year over year.
  • Berry Genomics Co.,Ltd Goodwill for the year ending December 31, 2019 was USD 1.93 M, a -1.24% change year over year.
Key data
Date Goodwill Total Assets Current Liabilities Total Non-Current Liabilities
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 000710.SZ

Berry Genomics Co.,Ltd

CEO Dr. Yang Gao
IPO Date April 22, 1997
Location China
Headquarters Building 5
Employees 1,448
Sector Healthcare
Industries
Description

Berry Genomics Co.,Ltd, a genomics company, develops and commercializes technologies for the life sciences and clinical applications in China. The company offers NGS- based tests for various genetic diseases and cancers from preconception to adulthood; WES test for inherited pathogenic mutations in the GCH1 gene associated with the metabolic disease Dopa-responsive dystonia; CNV-Seq test for indicating translocation at the end of chromosomes 2 and 8; RNA-Seq test to demonstrate the photo-induced protein dimerization of plant cryptochromes; and WGS test for genome wide detection of DNA variants, including SNP, CNV, Indel, and SV. It serves approximately 2,000 hospitals throughout Mainland China, Hong Kong, Macao, and Taiwan. The company serves various organizations and facilities, including hospitals, research institutions, universities, and corporations. Berry Genomics Co.,Ltd has a partnership with Personalis, Inc. The company was founded in 2010 and is headquartered in Beijing, China.

StockViz Staff

February 2, 2025

Any question? Send us an email